CoChat

Elevated Mouse Hepatic Betatrophin Expression Does Not Increase Human β-Cell Replication in the Transplant Setting

Open access
Jiao, Yang, Le Lay, John, Yu, Ming, Naji, Ali, Kaestner, Klaus H. · 2014 · Diabetes

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

The recent discovery of betatrophin, a protein secreted by the liver and white adipose tissue in conditions of insulin resistance and shown to dramatically stimulate replication of mouse insulin-producing β-cells, has raised high hopes for the rapid development of a novel therapeutic approach for the treatment of diabetes. At present, however, the effects of betatrophin on human β-cells are not known. Here we use administration of the insulin receptor antagonist S961, shown to increase betatrophin gene expression and stimulate β-cell replication in mice, to test its effect on human β-cells. Although mouse β-cells, in their normal location in the pancreas or when transplanted under the kidney capsule, respond with a dramatic increase in β-cell DNA replication, human β-cells are completely unresponsive. These results put into question whether betatrophin can be developed as a therapeutic approach for treating human diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db13-1435

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Elevated betatrophin expression does not stimulate replication of human β-cells. A: Random blood glucose levels of NOD-Scid mice treated with vehicle (n = 6) or the insulin receptor antagonist S961 (n = 10). Glucose levels in S961-treated mice were significantly elevated from day 1 to 7 (P < 0.001). B: Hepatic betatrophin mRNA levels in mice treated with vehicle (n = 3) or S961 (n = 4) as determined by quantitative RT-PCR. Levels of mRNA were normalized to those of TATA-box binding protein as the internal control and are expressed as fold over vehicle. *P < 0.05. C: Gonadal white adipose tissue betatrophin mRNA levels in mice treated with vehicle (n = 8) or S961 (n = 6) as determined by quantitative RT-PCR. β-Cell replication in NOD-Scid mice treated with vehicle or S961 was determined by BrdU incorporation (red signal). β-Cells were identified by insulin immunofluorescence staining (green). D: β-Cells in the endocrine pancreas of vehicle-treated mice. E: Transplanted human islets recovered from the kidney capsule of vehicle-treated mice. F: Transplanted mouse islets recovered from the kidney capsule of vehicle-treated mice. G: β-Cells in the endocrine pancreas of S961-treated mice. Note the frequent BrdU+ β-cells (yellow arrows). H: Transplanted human islets recovered from the kidney capsule of S961-treated mice. Insulin/BrdU double-positive cells are very rare. I: Transplanted mouse islets recovered from the kidney capsule of S961-treated mice. Note the frequent BrdU+ β-cells (yellow arrows). J: β-Cell replication was quantified as the percentage of BrdU+/insulin (Ins)+ double-positive cells of the total number of insulin+ cells from the six conditions shown in D–I. n = 5 for vehicle and for S961. **P < 0.01. β-Cell replication in transplanted mouse islets from 2-month-old or 12-month-old donor mice was also quantified separately. K: β-Cell replication was determined as the percentage of Ki67+/insulin+ double-positive cells of the total number of insulin+ cells in the six conditions shown in D–I. n = 5 for vehicle and for S961. **P < 0.01.
Figure 1 Elevated betatrophin expression does not stimulate replication of human β-cells. A: Random blood glucose levels of NOD-Scid mice treated with vehicle (n = 6) or the insulin receptor antagonist S961 (n = 10). Glucose levels in S961-treated mice were significantly elevated from day 1 to 7 (P < 0.001). B: Hepatic betatrophin mRNA levels in mice treated with vehicle (n = 3) or S961 (n = 4) as determined by quantitative RT-PCR. Levels of mRNA were normalized to those of TATA-box binding protein as the internal control and are expressed as fold over vehicle. *P < 0.05. C: Gonadal white adipose tissue betatrophin mRNA levels in mice treated with vehicle (n = 8) or S961 (n = 6) as determined by quantitative RT-PCR. β-Cell replication in NOD-Scid mice treated with vehicle or S961 was determined by BrdU incorporation (red signal). β-Cells were identified by insulin immunofluorescence staining (green). D: β-Cells in the endocrine pancreas of vehicle-treated mice. E: Transplanted human islets recovered from the kidney capsule of vehicle-treated mice. F: Transplanted mouse islets recovered from the kidney capsule of vehicle-treated mice. G: β-Cells in the endocrine pancreas of S961-treated mice. Note the frequent BrdU+ β-cells (yellow arrows). H: Transplanted human islets recovered from the kidney capsule of S961-treated mice. Insulin/BrdU double-positive cells are very rare. I: Transplanted mouse islets recovered from the kidney capsule of S961-treated mice. Note the frequent BrdU+ β-cells (yellow arrows). J: β-Cell replication was quantified as the percentage of BrdU+/insulin (Ins)+ double-positive cells of the total number of insulin+ cells from the six conditions shown in D–I. n = 5 for vehicle and for S961. **P < 0.01. β-Cell replication in transplanted mouse islets from 2-month-old or 12-month-old donor mice was also quantified separately. K: β-Cell replication was determined as the percentage of Ki67+/insulin+ double-positive cells of the total number of insulin+ cells in the six conditions shown in D–I. n = 5 for vehicle and for S961. **P < 0.01.CC BY-NC-ND · PubMed Central
Figure 2 No evidence for increased β-cell apoptosis in S961-treated mice. Apoptosis in NOD-Scid mice treated with vehicle or S961 was determined by TUNEL staining (red signal). β-Cells were identified by insulin immunofluorescence staining (green). A: β-Cells in the endocrine pancreas of vehicle-treated mice. B: Transplanted human islets recovered from the kidney capsule of vehicle-treated mice. C: Transplanted mouse islets recovered from the kidney capsule of vehicle-treated mice. D: β-Cells in the endocrine pancreas of S961-treated mice. E: Transplanted human islets recovered from the kidney capsule of S961-treated mice. F: Transplanted mouse islets recovered from the kidney capsule of S961-treated mice. G: Positive control for the TUNEL staining assay using DNAse-treated tissue.
Figure 2 No evidence for increased β-cell apoptosis in S961-treated mice. Apoptosis in NOD-Scid mice treated with vehicle or S961 was determined by TUNEL staining (red signal). β-Cells were identified by insulin immunofluorescence staining (green). A: β-Cells in the endocrine pancreas of vehicle-treated mice. B: Transplanted human islets recovered from the kidney capsule of vehicle-treated mice. C: Transplanted mouse islets recovered from the kidney capsule of vehicle-treated mice. D: β-Cells in the endocrine pancreas of S961-treated mice. E: Transplanted human islets recovered from the kidney capsule of S961-treated mice. F: Transplanted mouse islets recovered from the kidney capsule of S961-treated mice. G: Positive control for the TUNEL staining assay using DNAse-treated tissue.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Cited by

See all 120

Metadata

Authors
Jiao, Y., Le Lay, J., Yu, M., Naji, A., & Kaestner, K. H.
Affiliations
  • University of Pennsylvania (US)
  • Department of Genetics and Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
Corresponding author
Kaestner, Klaus H.
Venue
Diabetes
Published
2014-03-13
Volume
63
Issue
4
Pages
1283-1288
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2103877357
Cited by
118
References
13
Citations by year
2026: 1 · 2025: 4 · 2024: 4 · 2023: 1 · 2022: 6 · 2021: 3 · 2020: 7 · 2019: 5 · 2018: 9 · 2017: 15 · 2016: 17 · 2015: 29 · 2014: 17
FWCI
20.72
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • National Cancer Institute (P30CA016520)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK088383, U01DK089529, U01DK070430)
  • National Center for Research Resources (U42RR006042)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
betatrophin, beta-cell proliferation, human beta cells, beta cell transplantation, insulin receptor antagonist, diabetes treatment, species differences, DNA replication
MeSH terms
Angiopoietin-like Proteins, Angiopoietin-Like Protein 8, Adolescent, Adult, Animals, Child, Preschool, Female, Humans, Male, Middle Aged, Peptides, Receptor, Insulin, Transplantation, Heterologous, Islets of Langerhans Transplantation, Mice, SCID, Mice, Inbred NOD, Peptide Hormones, Cell Proliferation, Insulin-Secreting Cells, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.